Vogenx, Inc. (VOGX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $566.00; Common Stock, Value, IssuedUSD $526.00; Additional Paid in CapitalUSD $9.92M; Retained Earnings (Accumulated Deficit)USD $-11.70M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $566.00; Common Stock, Value, IssuedUSD $526.00; Additional Paid in CapitalUSD $9.92M; Retained Earnings (Accumulated Deficit)USD $-10.84M.
- 2025-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
Vogenx, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $566.00 | $526.00 | $9.92M | $-11.70M | $-1.78M | 3 month · $4.67K |
| 2026-03-31 | (m) | (m) | (m) | (m) | $-1.40M | 3 month · $-4.85K |
| 2025-12-31 | $566.00 | $526.00 | $9.92M | $-10.84M | $-919.24K | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | $-136.59K | 3 month · $2.62K |
| 2025-03-31 | (m) | (m) | (m) | (m) | $155.59K | 3 month · $2.62K |
| 2024-12-31 | (m) | (m) | (m) | (m) | $509.58K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |